Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution

<table>Overall survival based on HCT-CI scores and age. Patients are classified into different age groups from 20–39, 40–49, 50–59, 60–69, and &gt;70.</table>

International Scholarly Research Notices

fig4

Figure 4

Figure 4: Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution 

Figure 4 | Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution 